Latest "MAQUET Cardiovascular LLC" News Stories

14:09 EDT 18th July 2018 | BioPortfolio

Here are the most relevant search results for "MAQUET Cardiovascular LLC" found in our extensive news archives from over 250 global news sources.

More Information about MAQUET Cardiovascular LLC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MAQUET Cardiovascular LLC for you to read. Along with our medical data and news we also list MAQUET Cardiovascular LLC Clinical Trials, which are updated daily. BioPortfolio also has a large database of MAQUET Cardiovascular LLC Companies for you to search.

Showing "MAQUET Cardiovascular" News Articles 1–25 of 2,200+

Wednesday 18th July 2018

Physicians’ Education Resource® Presents the 2018 New York Advanced Practice Collaborative

Leading experts in primary care will gather to discuss strategies to improve the patient-provider relationship Physicians’ Education Resource®, LLC (PER®), announces the 2018 New York Advanced Practice Collaborative to be held on September 15, 2018, at the Westin New York Grand Central in New York City. The conference will be co-chaired by Lawrence...

Appointments: New CEO For Silence Therapeutics, Medical Heads Join Merck, Breath Therapeutics, Immusoft

David Solomon’s entrance as Silence Therapeutics’ new CEO leads this week’s new hires. While Ireland-based Malin shakes up its board...    

Poxel Announces Favorable Results for PXL770 Phase 1b Multiple Ascending Dose Trial and Drug-Drug Interaction Study

PXL770 observed to have a favorable safety and pharmacokinetic profile in the complete Phase 1 program PXL770 is advancing into a Phase 2a proof-of-concept program for NASH POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic...

Tuesday 17th July 2018

HIV infection doubles risk of heart disease, global study finds

(University of Edinburgh) People infected with HIV are twice as likely to suffer from heart disease, research has found. Analysis of global figures reveals that HIV-associated cardiovascular disease has more than tripled in the past 20 years as more people are living longer with the virus. The greatest impact is in sub-Saharan Africa and Asia Pacific regions, with Swaziland, Botswana and Lesotho ...

PCI patients discharged against medical advice twice as likely to be readmitted

(American College of Cardiology) In a new study, researchers found discharge against medical advice as the strongest predictor of 30-day unplanned readmissions in heart attack patients. While only a small number of patients choose to discharge against medical advice following percutaneous coronary intervention (PCI), these patients are twice as likely to be readmitted to the hospital, according to...

Eisai's Obesity Drug Belviq Passes Cardiovascular Outcomes Test

The Japanese pharma says it will discuss the data with US FDA, with hopes of potential to incorporate secondary endpoint...   

How Big a Bite Does Cardiovascular Disease Take Out of Family Budgets?

Nearly one in ten low-income families with health insurance and at least one member with atherosclerotic CVD had catastrophic-level healthcare costs in 2014–2015.

Global Electrocardiograph ECG Market Segmented by Product, Technology, Lead Type, End user and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global electrocardiograph ECG market is expected to witness a CAGR of approximately 5%. North America is expected to have highest market share and APAC is expected to witness the highest CAGR.Rising Incidences of Cardiac Diseases due to Change in Living PatternThe increase in cardiovascular diseases is a direct cause for the increase in demand for ECG devices. Prevalence of CVD is strongly dri...

Florida Hospital Pepin Heart Institute First in Tampa Bay to Offer New Option to Treat Uncontrolled High Blood Pressure

The hospital is now enrolling patients in a new clinical trial for uncontrolled high blood pressure. TAMPA, Fla. (PRWEB) July 17, 2018 Florida Hospital Pepin Heart Institute is the only hospital in Tampa Bay and one of only two hospitals in Florida, now enrolling patients who have unsuccessfully tried to control high blood pressure with medication to participate in a new clinical research study c...

Vizient Announces Product Categories for Quarter 3 National Group Buys Program

Siemens Healthineers is the Quarter 3 Featured Supplier Vizient, Inc., today announced the product categories and supplier savings opportunities available as part of its Quarter 3 National Group Buys Program available July 1 through September 30, 2018. The

Global Ambulatory Cardiac Monitoring Devices Market 2018-2022 | Development of New Products | Technavio

The global ambulatory cardiac monitoring devices market 2018-2022 is expected to post a CAGR of more than 5% during the forecast period, according to the latest market research report by Technavio. This press release features multimedia. View the full release here:

Phoenix Health Systems Selected for Multi-Year IT Outsourcing Partnership by Southwest Mississippi Regional Medical Center

Rural Mississippi hospital taps top-rated health IT services provider for software and hardware infrastructure support Phoenix Health Systems, the leading independent provider of hospital IT outsourcing and consulting services, today announced that Southwest Mississippi Regional Medical Center has signed a long-term contract for IT department...

High vinculin levels help keep aging fruit fly hearts young

A new discovery in how heart muscles maintain their shape in fruit flies sheds light on the crucial relationship between cardiac function, metabolism, and longevity. Researchers have discovered that maintaining high levels of the protein vinculin confers health benefits to fruit flies. Their work shows that fruit flies bred to produce 50 percent more vinculin enjoyed better cardiovascular health a...

OMEICOS Therapeutics Announces Compelling First-in-Human Data on Lead Compound OMT-28 and Prepares Phase 2 Trial in Atrial Fibrillation

-- High-resolution electrocardiography strongly supports OMT-28’s claim for low pro-arrhythmic risk -- OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced results from its first-in-human clinical...

Monday 16th July 2018

Medical News Today: Large study reviews the cardiovascular benefits of walnuts

The results of a meta-review of 25 years worth of research on the cardiovascular effects of nuts are in: a walnut-enriched diet keeps your heart healthy.

Mesoblast Enters Into Strategic Cardiovascular Alliance for China With Tasly Pharmaceutical Group

NEW YORK and MELBOURNE, Australia, July 17, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that it has entered into a strategic alliance with one of China’s largest pharmaceutical companies, Tasly Pharmaceutical Group (SHA: 600535; Tasly), for the development, manufacture and commercialization in China of Mesoblast’s allogeneic mesenchymal precursor cel...

Beyond Rebates: PhRMA Wants HHS To ‘De-Link’ Supply Chain Compensation From List Price

Focus should not be limited to rebates in Medicare Part D, manufacturers advise in comments on HHS drug pricing blueprint...   

20182023 Global Guide Wire Consumption Market Report [Report Updated: 06062018] Prices from USD $4660

In this report, LP Information covers the present scenario with the base year being 2017 and the growth prospects of global Guide Wire market for 20182023.Peripheral guidewires have multiple layers which includes central core, distal tip and outer coating. Central core is generally made up of stainless steel or nitinol which posses' superior torque characteristics. Distal tip has variable length a...

Cardiovascular Systems, Inc. Signs International Distribution Agreement with OrbusNeich

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral Orbital Atherectomy Systems (OAS) outside the United States and Japan. OrbusNeich manufactures and sells an extensive portfolio of coronary and peripheral products including stents, balloons an...

Finance Watch: 2018 Biopharma VC Investment Could Beat 2017 One Quarter Ahead Of Schedule

With biopharma venture capital investment of $9.67bn during the first half, 2018's total is on track to beat 2017 in...   

Multivitamins to Reduce Cardiovascular Mortality: Still No Evidence

Results from a systematic review and meta-analysis of 18 observational and randomized, controlled studies

Global Immunoassays Market Segmented by Technology, Therapeutics Area and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global Immunoassay market has been estimated to reach 17.16 billion in 2017. : The global Immunoassays market is expected to register a CAGR of 9.7% during the forecast period, 2018 to 2023. North America dominates the market due to the technological advancement in the immunoassay products and rising incidence in the chronic diseases like thyroid, cardiovascular diseases.High Sensitivity and S...

Plant-Based Products Not Faring Well in Blood Pressure Study

NewsScientists instead suggest using a naturally occurring protein to combat hypertension.

Technavio: Global Defibrillator Market Report - Market Size Prediction and Analysis Through 2022

The global defibrillator market 2018-2022 report has been added to Technavio’s

Voluntis: Results of the eCO Trial Published in the Journal of Clinical Oncology Informatics

Regulatory News: Voluntis (Paris:VTX) (the “Company” or “Voluntis” - ticker: VTX - ISIN Code: FR 0004183960), a company specialized in digital therapeutics, today announces that results for eCO, the digital therapeutic it developed for women with ovarian cancer in partnership with AstraZeneca and the National Cancer Institute, have been p...

Quick Search


News Quicklinks